IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,065 | +2.2% | 45,522 | -7.6% | 0.10% | +10.2% |
| Q2 2023 | $2,021 | -3.6% | 49,252 | -16.0% | 0.09% | -11.1% |
| Q1 2023 | $2,096 | -24.6% | 58,652 | -20.3% | 0.10% | -35.7% |
| Q4 2022 | $2,778 | -99.9% | 73,547 | +20.7% | 0.15% | -5.5% |
| Q3 2022 | $2,695,000 | +192.3% | 60,937 | +144.7% | 0.16% | +136.2% |
| Q2 2022 | $922,000 | +86.6% | 24,900 | +86.6% | 0.07% | +115.6% |
| Q1 2022 | $494,000 | -57.7% | 13,344 | -65.3% | 0.03% | -78.1% |
| Q4 2021 | $1,169,000 | +48.5% | 38,430 | +63.7% | 0.15% | +39.0% |
| Q3 2021 | $787,000 | – | 23,474 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |